Validation of the Chinese drug hypersensitivity quality of life questionnaire: Role of delabeling.

Hugo W F MakElsie T S ChanJackie S H YimElaine LeeDorothy L Y LamValerie ChiangPhilip H Li

Published in: Asia Pacific allergy (2023)

The Chinese DrHy-Q is reliable and valid for HRQoL assessment. PA delabeling significantly benefits patients' HRQoL. Future larger-scale studies are warranted to corroborate our findings.

Keyphrases

end stage renal disease
newly diagnosed
peritoneal dialysis
prognostic factors
emergency department
drug induced
patient reported
current status
patient reported outcomes